By: Strides  09-12-2011

We have the unique ability to deliver products in varied packaging formats including vials (liquid and dry powder), pre filled syringes (PFS), suspension injections, ampoules and lyophilized forms.

In 2010, we forayed into biopharmaceuticals through the acquisition of Bangalore-based biotechnology firm,

Solutions. The acquisition gives us immediate access to a pipeline of 8 biosimilars, of which 5 are monoclonal antibodies for cancer treatment which further strengthens our oncology portfolio.

In addition, we also get access to both, high expression mammalian and microbial platform-based development capabilities.

  • Domain focus on penems, pencillins, oncology, ophthalmology, peptides and biologicals
  • 30+ products under development
  • 40+ ANDAs in the last two years
  • Strong capabilities in assessment and evaluation of intellectual property (IP) and regulatory filings
  • IP-led licensing partnerships
  • One of the largest lyophilisation facilities in the world

Other products and services from Strides


Strides - branded ROL prorange

We are among the select few pharmaceutical companies operating in key critical care segments in India to have our own manufacturing facilities in the country. Ray of Life products are manufactured to the most exacting standards prescribed anywhere in the world.


Strides - pharma products

Our range of products includes nutraceuticals and Rx soft gelatine capsules, high potency drugs like immunosuppressants, anti-retorvirals, anti-Tb and anti-malarial drugs, and oral solids in wide ranging therapies. The Bangalore oral dosage forms facility has also been pre-qualified by WHO for the manufacture of anti-retroviral drugs , and by the USFDA for ARVs under the PEPFAR programme.